Skip to content

Opening book details…

Can I read The Role of Systemic High-dose Cytarabine in the Treatment of Central Nervous System Leukemia Clinical Results in 46 Patients on EtoBox?

The Role of Systemic High-dose Cytarabine in the Treatment of Central Nervous System Leukemia Clinical Results in 46 Patients by Enrica Morra; Mario Lazzarino; Ercole Brusamolino; Guido Pagnucco; Carlo Castagnola; Paolo Bernasconi; Ester Orlandi; Alessandro Corso; Alberto Santagostino; Carlo Bernasconi is a Medicine article available to read on EtoBox.

What is The Role of Systemic High-dose Cytarabine in the Treatment of Central Nervous System Leukemia Clinical Results in 46 Patients about?

Background. Given the good penetration of systemic high-dose cytarabine (HDara-C) into the cerebrospinal fluid (CSF), this approach was used to treat patients with central nervous system (CNS) leukemia, either isolated or with concurrent extraneurologic disease (END). Methods. From 1983 to 1991,46 adults with CNS involvement were treated with systemic HDara-C: 25 had acute lymphoblastic leukemia (ALL), 15 had high-grade non-Hodgkin lymphoma (NHL), 5 had acute myelogenous leukemia (AML), and 1 had lymphoid blast crisis of chronic myelogenous leukemia. Induction consisted of HDara-C 3 g/m' every 12 hours, by 3-hour infusion, for 8 doses (30 patients), or 6 doses (16 patients), followed by 4 doses at day 21. Results. Of 46 patients, 29 (63%) achieved complete remission (CR): 15/15 with isolated CNS leukemia, and 14/31 (45%) with CNS and concurrent marrow or lymph node disease. Of 17 patients not meeting CR criteria because of persistent END, 11 showed complete CNS response. The first 10 remitters were consolidated with monthly 4-dose courses of HDara-C. The remaining 19 received postinduction multidrug chemotherapy (including vincristine, doxorubicin, cyclophosphamide, Lasparaginase,

Who reads The Role of Systemic High-dose Cytarabine in the Treatment of Central Nervous System Leukemia Clinical Results in 46 Patients?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Enrica Morra; Mario Lazzarino; Ercole Brusamolino; Guido Pagnucco; Carlo Castagnola; Paolo Bernasconi; Ester Orlandi; Alessandro Corso; Alberto Santagostino; Carlo Bernasconi
Publisher
John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0008-543X)
Published
1993
Language
EN
Field
Medicine (Health Sciences)

More by Enrica Morra; Mario Lazzarino; Ercole Brusamolino; Guido Pagnucco; Carlo Castagnola; Paolo Bernasconi; Ester Orlandi; Alessandro Corso; Alberto Santagostino; Carlo Bernasconi

Browse all works by Enrica Morra; Mario Lazzarino; Ercole Brusamolino; Guido Pagnucco; Carlo Castagnola; Paolo Bernasconi; Ester Orlandi; Alessandro Corso; Alberto Santagostino; Carlo Bernasconi